Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata in Saudi Arabia is costly, mainly due to lost work and medication expenses, needing better diagnosis, treatment, and care.

The guidelines help doctors diagnose and treat hormone-related disorders in women.

This special edition focuses on the unique aspects of treating skin conditions in women, including during pregnancy and in diverse populations like women of color and transgender patients.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

Health Education England is moving forward with phase two of their cosmetic intervention project after a successful summit and plans for future training standards.

Proscar and Propecia, two drugs with the same ingredient but different dosages, have different prices, showing price discrimination in the pharmaceutical industry.

Dermatopathologists must consider both birth sex and gender identity to accurately diagnose and treat transgender patients.

Skin diseases have a small to moderate impact on the quality of life of patients in Goa, India.

Improving education, insurance, and support can help scarring alopecia patients access better care.

Polish doctors find performance-enhancing substances unethical and want more knowledge to combat doping in sports.

Ayurveda-based care improved quality of life for breast cancer patients without serious side effects.

Personalized hair care strategies are needed for Black cancer patients to prevent hair loss during chemotherapy.

Dermatologists should understand cultural practices and communicate empathetically to effectively treat skin conditions in children and teens of color.

Companies agreed to stop false advertising about their products' health benefits.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Direct-to-consumer teledermatology is growing fast but raises concerns about quality of care and doctor-patient relationships.

Lupus patients often face depression and anxiety due to physical changes, with education and insurance affecting their mental health.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Most nurses have negative attitudes towards mental illness, highlighting the need for training to improve their views.

Collider bias can mislead our understanding of COVID-19 risk and severity.

Patients need better counseling and resources for managing chemotherapy-induced hair loss.

Medical care for transgender youth should be individualized and supportive.

Accurate diagnosis and timely, tailored treatments improve outcomes in obstetrics and gynecology.

COVID-19 changed dermatology by increasing telemedicine and highlighting healthcare disparities.

There are various tools available to help psoriasis patients manage their condition, but their effectiveness is unclear and they face issues like lack of financial support.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Europe strengthened medicine regulations, increased protection against counterfeit drugs, and made it tougher to challenge comparative advertising, while also focusing on patent law enforcement and updating plant protection rules.

European dermatological guidelines vary in quality, with some highly rated, but improvements are needed in applicability and consistency.

Palbociclib generally maintains or improves quality of life in advanced breast cancer patients.